Teleflex Reports Q4 2024 Earnings with Noncash Goodwill Impairment and Guidance for 2025
Teleflex (TFX) reported Q4 2024 revenue of $795.4 million, a 2.8% year-over-year increase, but disclosed a $240 million noncash goodwill impairment in its Interventional Urology North America segment. The company also outlined challenges for 2025, including subdued revenue growth, contract losses, and potential impacts from tariffs and foreign exchange.
Topics: earnings report goodwill impairment guidance market challenges revenue growth